Antonio Fabozzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antonio Fabozzi has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Paolo Palange
12 shared publications- Matteo Bonini
Pulmonology Unit, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, 00185 Rome, Italy
8 shared publications - Paolo Palange
Pulmonology Unit, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, 00185 Rome, Italy
8 shared publications Matteo Bonini
7 shared publications- Ambra Nicolai
Pulmonology Division, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy
5 shared publications - Federica Olmati
Pulmonology Division, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy
5 shared publications
Latest Publications
- 31 October 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (6) , 301
How obstructive sleep apnea differs in COPD and asthma: insights from a clinical and functional study
- 31 October 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (6) , 301
How obstructive sleep apnea differs in COPD and asthma: insights from a clinical and functional study
- Open Access
- 30 October 2026
- Published by Elsevier in Sleep Medicine
- Vol. 149
The impact of diagnostic criteria on the detection of nocturnal hypoventilation in adult amyotrophic lateral sclerosis patients
- 30 October 2026
- Published by Elsevier in Sleep Medicine
- Vol. 149
Open AccessThe impact of diagnostic criteria on the detection of nocturnal hypoventilation in adult amyotrophic lateral sclerosis patients
- Open Access
- 12 September 2026
- Published by Wolters Kluwer Health in Medical Gas Research
- Vol. 17 (1) , 285-300
Oxygen, carbon dioxide, and nitric oxide: role in the pathophysiology of obstructive sleep apnea
Obstructive sleep apnea is a prevalent sleep-related breathing disorder with recurrent episodes of upper airway collapse during sleep, leading to cyclic blood gas fluctuations. Oxygen, carbon dioxide, and nitric oxide play a crucial role in the pathophysiology. This narrative review aims to explore the role of gases in obstructive sleep apnea pathophysiology, focusing on the molecular pathways and effects of chronic intermittent hypoxia, intermittent hypercapnia, and nitric oxide dysregulation. Chronic intermittent hypoxia stimulates molecular pathways such as hypoxia-inducible factor-1α and inflammatory cascades such as nuclear factor kappa B, leading to oxidative stress, endothelial dysfunction, and sympathetic overactivation. Intermittent hypercapnia impacts on chemoreflex sensitivity, ventilatory instability, and autonomic function, with emerging evidence of both pathogenic and potentially beneficial effects. Nitric oxide, which modulates airway tone, vascular reactivity, and immune control, presents a reduced bioavailability in patients with obstructive sleep apnea. These three gas mediators contribute to the complex pathophysiology of obstructive sleep apnea and underlie the long-term cardiovascular, metabolic, and neurocognitive risks of obstructive sleep apnea. Appropriately prioritizing the relationship between these gases and the pathophysiology of obstructive sleep apnea contributes to a new understanding of the disease and new treatment approaches in the future.
- 12 September 2026
- Published by Wolters Kluwer Health in Medical Gas Research
- Vol. 17 (1) , 285-300
Open AccessOxygen, carbon dioxide, and nitric oxide: role in the pathophysiology of obstructive sleep apnea
Obstructive sleep apnea is a prevalent sleep-related breathing disorder with recurrent episodes of upper airway collapse during sleep, leading to cyclic blood gas fluctuations. Oxygen, carbon dioxide, and nitric oxide play a crucial role in the pathophysiology. This narrative review aims to explore the role of gases in obstructive sleep apnea pathophysiology, focusing on the molecular pathways and effects of chronic intermittent hypoxia, intermittent hypercapnia, and nitric oxide dysregulation. Chronic intermittent hypoxia stimulates molecular pathways such as hypoxia-inducible factor-1α and inflammatory cascades such as nuclear factor kappa B, leading to oxidative stress, endothelial dysfunction, and sympathetic overactivation. Intermittent hypercapnia impacts on chemoreflex sensitivity, ventilatory instability, and autonomic function, with emerging evidence of both pathogenic and potentially beneficial effects. Nitric oxide, which modulates airway tone, vascular reactivity, and immune control, presents a reduced bioavailability in patients with obstructive sleep apnea. These three gas mediators contribute to the complex pathophysiology of obstructive sleep apnea and underlie the long-term cardiovascular, metabolic, and neurocognitive risks of obstructive sleep apnea. Appropriately prioritizing the relationship between these gases and the pathophysiology of obstructive sleep apnea contributes to a new understanding of the disease and new treatment approaches in the future.
- Open Access
- 5 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (15) , 2410
Rethinking Long-Term Follow-Up of CPAP Therapy in Obstructive Sleep Apnea: Toward Personalized and Integrated Care
Background: Although the diagnostic and treatment pathway for Obstructive Sleep Apnea (OSA) is well established, long-term management is still not standardized. Methods: We conducted a narrative review of studies published between 2000 and 2026 in PubMed/MEDLINE. Results: Continuous Positive Airway Pressure (CPAP) adherence and healthcare resource allocation remain the real critical issue of long-term management for OSA patients. Early proactive interventions like phone calls and early medical visits may be particularly valuable for improving CPAP nightly usage. Telemedicine, educated and trained home-care providers or primary care can lead to improved adherence, long-term monitoring and earlier identification of treatment-related issues. Patient-reported outcomes, comorbidities, endotypes, and phenotypic stratification should be integrated into follow-up management. Conclusions: OSA long-term care should shift from a device-centered approach toward a personalized, patient-centered model with the integration of multidimensional risk stratification, multidisciplinary care, telemedicine and primary care support.
- 5 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (15) , 2410
Open AccessRethinking Long-Term Follow-Up of CPAP Therapy in Obstructive Sleep Apnea: Toward Personalized and Integrated Care
Background: Although the diagnostic and treatment pathway for Obstructive Sleep Apnea (OSA) is well established, long-term management is still not standardized. Methods: We conducted a narrative review of studies published between 2000 and 2026 in PubMed/MEDLINE. Results: Continuous Positive Airway Pressure (CPAP) adherence and healthcare resource allocation remain the real critical issue of long-term management for OSA patients. Early proactive interventions like phone calls and early medical visits may be particularly valuable for improving CPAP nightly usage. Telemedicine, educated and trained home-care providers or primary care can lead to improved adherence, long-term monitoring and earlier identification of treatment-related issues. Patient-reported outcomes, comorbidities, endotypes, and phenotypic stratification should be integrated into follow-up management. Conclusions: OSA long-term care should shift from a device-centered approach toward a personalized, patient-centered model with the integration of multidimensional risk stratification, multidisciplinary care, telemedicine and primary care support.
- Open Access
- 1 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (15) , 2328
Optimizing CPAP Adherence in Obstructive Sleep Apnea: A Narrative Review of Practical Strategies for Everyday Clinical Care
Background: Continuous positive airway pressure (CPAP) is the primary treatment for obstructive sleep apnea (OSA). Despite improvements in CPAP technology and management, adherence to therapy remains one of the main challenges to be addressed. Methods: We conducted a narrative review through PubMed (1995–2026). Studies were selected by clinical relevance, methodological quality and expert consensus. Results: OSA treatment outcomes are poor when CPAP adherence is defined as four hours per night. The first step in improving adherence is active patient involvement. This involves explaining what OSA is, its consequences, what PAP therapy is, and its potential benefits. The choice of the right mask is the first personalized step in CPAP adherence. OSA phenotype and endotype traits may help personalize treatment in selected patients, although their role in predicting CPAP adherence needs to be studied in greater depth. Problems during the first night and the first month are the main predictors of future adherence. Strategies such as cognitive behavioral therapy or motivational enhancement can improve adherence, especially during the initial period. Long-term adherence can be predicted from the initial period and maintained through scheduled follow-up. Group meetings, telephone calls and telemedicine interactions are also a valid way of improving adherence. Conclusions: Patients should initially be educated about how their symptoms are related to sleep apnea and how CPAP treatment could resolve them. The key to improving CPAP adherence is involving patients in personalized treatment with scheduled follow-up, particularly during the initial treatment period.
- 1 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (15) , 2328
Open AccessOptimizing CPAP Adherence in Obstructive Sleep Apnea: A Narrative Review of Practical Strategies for Everyday Clinical Care
Background: Continuous positive airway pressure (CPAP) is the primary treatment for obstructive sleep apnea (OSA). Despite improvements in CPAP technology and management, adherence to therapy remains one of the main challenges to be addressed. Methods: We conducted a narrative review through PubMed (1995–2026). Studies were selected by clinical relevance, methodological quality and expert consensus. Results: OSA treatment outcomes are poor when CPAP adherence is defined as four hours per night. The first step in improving adherence is active patient involvement. This involves explaining what OSA is, its consequences, what PAP therapy is, and its potential benefits. The choice of the right mask is the first personalized step in CPAP adherence. OSA phenotype and endotype traits may help personalize treatment in selected patients, although their role in predicting CPAP adherence needs to be studied in greater depth. Problems during the first night and the first month are the main predictors of future adherence. Strategies such as cognitive behavioral therapy or motivational enhancement can improve adherence, especially during the initial period. Long-term adherence can be predicted from the initial period and maintained through scheduled follow-up. Group meetings, telephone calls and telemedicine interactions are also a valid way of improving adherence. Conclusions: Patients should initially be educated about how their symptoms are related to sleep apnea and how CPAP treatment could resolve them. The key to improving CPAP adherence is involving patients in personalized treatment with scheduled follow-up, particularly during the initial treatment period.
- Open Access
- 11 June 2026
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
Bilateral diaphragmatic paralysis as clinical onset of Eosinophilic Granulomatosis with Polyangiitis: a case report
Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare small-vessel vasculitis which may affect different organs, leading to a highly variable and often challenging initial clinical presentation. We report the case of a 67-year-old man presenting with acute non-exertional dyspnea and chest tightness. He had an history of adult-onset asthma, chronic rhinosinusitis and peripheral eosinophilia. Imaging revealed bilateral diaphragmatic elevation, and needle electromyography confirmed diaphragmatic paralysis. The combination of his history and the presence of eosinophilic exudative pleural effusion, transient pulmonary ground-glass opacities and turbinate eosinophilic extravascular inflammation, led us to diagnose EGPA characterized by bilateral diaphragm paralysis. EGPA should be considered in patients with unexplained diaphragmatic paralysis associated with appropriate clinical and laboratory picture, as prompt recognition is crucial for the prognosis.
- 11 June 2026
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
Open AccessBilateral diaphragmatic paralysis as clinical onset of Eosinophilic Granulomatosis with Polyangiitis: a case report
Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare small-vessel vasculitis which may affect different organs, leading to a highly variable and often challenging initial clinical presentation. We report the case of a 67-year-old man presenting with acute non-exertional dyspnea and chest tightness. He had an history of adult-onset asthma, chronic rhinosinusitis and peripheral eosinophilia. Imaging revealed bilateral diaphragmatic elevation, and needle electromyography confirmed diaphragmatic paralysis. The combination of his history and the presence of eosinophilic exudative pleural effusion, transient pulmonary ground-glass opacities and turbinate eosinophilic extravascular inflammation, led us to diagnose EGPA characterized by bilateral diaphragm paralysis. EGPA should be considered in patients with unexplained diaphragmatic paralysis associated with appropriate clinical and laboratory picture, as prompt recognition is crucial for the prognosis.
- Open Access
- 28 May 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
Large Language Models in Respiratory Care: Safety and Clinical Integration
Background: Large language models (LLMs) are rapidly entering respiratory medicine workflows. Their clinical role remains unclear. A central concern is whether they function as autonomous decision makers or as tools that depend on clinician input. Methods: We conducted a structured narrative review across three domains aligned with respiratory practice. Bedside clinical decision support and triage, pulmonary function test (PFT)/spirometry interpretation, and chest X-ray (CXR) reporting. We included quantitative studies comparing LLMs or specialised AI systems with clinician performance, and extracted accuracy, agreement, and safety-critical failure modes. Results: At bedside, LLMs approached expert diagnosis in straightforward cases, but performance fell in highly-complex or multi-step management tasks. The dominant error was omission of required actions, unsafe under-triage or incomplete plans. In PFTs, guideline-anchored and spirogram-trained LLMs achieved high agreement and reduced inter-observer variability on structured inputs. In contrast, generalist LLMs showed only moderate reliability and inconsistent handling of borderline or mixed patterns. In CXR reporting, chest-specific multimodal systems outperformed generalist LLMs, with fewer hallucinations and better clinical acceptability; yet clinically relevant discrepancies persisted without radiologist review. Conclusions: Across domains, AI does not replace respiratory expertise. When inputs are complete, structured, and guideline-concordant, outputs stabilise and add value. When inputs are ambiguous or incomplete, errors expand, often through dangerous omissions. Safe deployment therefore requires specialised training, strict input structure, and continuous clinician oversight.
- 28 May 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
Open AccessLarge Language Models in Respiratory Care: Safety and Clinical Integration
Background: Large language models (LLMs) are rapidly entering respiratory medicine workflows. Their clinical role remains unclear. A central concern is whether they function as autonomous decision makers or as tools that depend on clinician input. Methods: We conducted a structured narrative review across three domains aligned with respiratory practice. Bedside clinical decision support and triage, pulmonary function test (PFT)/spirometry interpretation, and chest X-ray (CXR) reporting. We included quantitative studies comparing LLMs or specialised AI systems with clinician performance, and extracted accuracy, agreement, and safety-critical failure modes. Results: At bedside, LLMs approached expert diagnosis in straightforward cases, but performance fell in highly-complex or multi-step management tasks. The dominant error was omission of required actions, unsafe under-triage or incomplete plans. In PFTs, guideline-anchored and spirogram-trained LLMs achieved high agreement and reduced inter-observer variability on structured inputs. In contrast, generalist LLMs showed only moderate reliability and inconsistent handling of borderline or mixed patterns. In CXR reporting, chest-specific multimodal systems outperformed generalist LLMs, with fewer hallucinations and better clinical acceptability; yet clinically relevant discrepancies persisted without radiologist review. Conclusions: Across domains, AI does not replace respiratory expertise. When inputs are complete, structured, and guideline-concordant, outputs stabilise and add value. When inputs are ambiguous or incomplete, errors expand, often through dangerous omissions. Safe deployment therefore requires specialised training, strict input structure, and continuous clinician oversight.
- Open Access
- 7 May 2026
- Published by MDPI AG in Preprints.org
Optimizing CPAP Adherence in Obstructive Sleep Apnea: Practical Strategies for Everyday Clinical Care
Background: Continuous positive airway pressure (CPAP) is the primary treatment for Obstructive Sleep Apnea (OSA). Despite improvements in CPAP technology and management, adherence to therapy remains one of the main issues to be fixed. Methods: We conducted a narrative review through PubMed (1995-2025). Studies were selected by clinical relevance, methodological quality and expert consensus. Results: OSA treatment outcomes are poor when CPAP adherence is defined as four hours per night. The first step in improving adherence is active patient involvement. This involves explaining what OSA is, its consequences, what PAP therapy is, and its potential benefits. The right mask should be chosen for each patient; a nasal mask should be the first choice according to the Starling resistor model. OSA endotype and phenotype traits could be used to predict adherence, guide adjunct therapy, or suggest titration. Problems during the first night and the first month are the main predictors of future adherence. Strategies such as cognitive behavioral therapy or motivational enhancement can improve adherence, especially during the initial period. Long-term adherence can be predicted by the initial one and maintained with scheduled follow-up. Group meetings, telephone calls and telemedicine interactions are also a valid way of improving adherence. Conclusions: A Patients should initially be educated about how their symptoms are related to sleep apnoea and how CPAP treatment could resolve them. The key to improving CPAP adherence is to involve patients in personalised treatment with scheduled follow-up, particularly during the initial treatment period.
- 7 May 2026
- Published by MDPI AG in Preprints.org
Open AccessOptimizing CPAP Adherence in Obstructive Sleep Apnea: Practical Strategies for Everyday Clinical Care
Background: Continuous positive airway pressure (CPAP) is the primary treatment for Obstructive Sleep Apnea (OSA). Despite improvements in CPAP technology and management, adherence to therapy remains one of the main issues to be fixed. Methods: We conducted a narrative review through PubMed (1995-2025). Studies were selected by clinical relevance, methodological quality and expert consensus. Results: OSA treatment outcomes are poor when CPAP adherence is defined as four hours per night. The first step in improving adherence is active patient involvement. This involves explaining what OSA is, its consequences, what PAP therapy is, and its potential benefits. The right mask should be chosen for each patient; a nasal mask should be the first choice according to the Starling resistor model. OSA endotype and phenotype traits could be used to predict adherence, guide adjunct therapy, or suggest titration. Problems during the first night and the first month are the main predictors of future adherence. Strategies such as cognitive behavioral therapy or motivational enhancement can improve adherence, especially during the initial period. Long-term adherence can be predicted by the initial one and maintained with scheduled follow-up. Group meetings, telephone calls and telemedicine interactions are also a valid way of improving adherence. Conclusions: A Patients should initially be educated about how their symptoms are related to sleep apnoea and how CPAP treatment could resolve them. The key to improving CPAP adherence is to involve patients in personalised treatment with scheduled follow-up, particularly during the initial treatment period.
- Open Access
Asthma and Obstructive Sleep Apnea Overlap Syndrome Identifies a Phenotype of Sleep Instability and Increased Psychological Burden
Background: The alternative Overlap Syndrome (aOVS), the coexistence of bronchial asthma and Obstructive Sleep Apnea (OSA), represents a distinct clinical phenotype associated with worse clinical outcomes, but little is yet known about its characteristics. We aimed to investigate differences in sleep stability and clinical burden between OSA and aOVS patients matched for age, gender, BMI and Apnea-Hypopnea Index (AHI). Methods: 45 aOVS and 45 OSA patients were compared using demographic, clinical and polysomnographic data. Results: Patients with aOVS exhibited significantly higher odds ratio product (ORP) values for total sleep time (ORPmed: 0.8 ± 0.2 vs. 0.5 ± 0.1, p < 0.001) and Non-Rapid Eye Movement (ORPnr: 0.7 ± 0.3 vs. 0.4 ± 0.1, p < 0.001) sleep compared with OSA patients. Furthermore, patients with aOVS showed a significantly higher risk of developing clinically significant anxiety and fatigue, showing a significantly higher General Anxiety Disorder-7 (GAD-7: 8.7 ± 5.6 vs. 5.7 ± 4.7, p = 0.02) and significantly higher prevalence of fatigue (71% vs. 41%, p = 0.01). These associations remained significant after multivariable adjustment and were independent of OSA severity (AHI). Conclusions: Our findings support the concept that aOVS is characterised by significantly more unstable sleep and a greater psychological burden, even after matching with OSA patients for age, gender, BMI and AHI. Our study also highlights the need to integrate traditional sleep measures with more recent ones, such as ORP, in order to better capture the multidimensional burden of aOVS.
Open AccessAsthma and Obstructive Sleep Apnea Overlap Syndrome Identifies a Phenotype of Sleep Instability and Increased Psychological Burden
Background: The alternative Overlap Syndrome (aOVS), the coexistence of bronchial asthma and Obstructive Sleep Apnea (OSA), represents a distinct clinical phenotype associated with worse clinical outcomes, but little is yet known about its characteristics. We aimed to investigate differences in sleep stability and clinical burden between OSA and aOVS patients matched for age, gender, BMI and Apnea-Hypopnea Index (AHI). Methods: 45 aOVS and 45 OSA patients were compared using demographic, clinical and polysomnographic data. Results: Patients with aOVS exhibited significantly higher odds ratio product (ORP) values for total sleep time (ORPmed: 0.8 ± 0.2 vs. 0.5 ± 0.1, p < 0.001) and Non-Rapid Eye Movement (ORPnr: 0.7 ± 0.3 vs. 0.4 ± 0.1, p < 0.001) sleep compared with OSA patients. Furthermore, patients with aOVS showed a significantly higher risk of developing clinically significant anxiety and fatigue, showing a significantly higher General Anxiety Disorder-7 (GAD-7: 8.7 ± 5.6 vs. 5.7 ± 4.7, p = 0.02) and significantly higher prevalence of fatigue (71% vs. 41%, p = 0.01). These associations remained significant after multivariable adjustment and were independent of OSA severity (AHI). Conclusions: Our findings support the concept that aOVS is characterised by significantly more unstable sleep and a greater psychological burden, even after matching with OSA patients for age, gender, BMI and AHI. Our study also highlights the need to integrate traditional sleep measures with more recent ones, such as ORP, in order to better capture the multidimensional burden of aOVS.